Analysis of polymorphism in the survivin gene promoter as a potential risk factor for head and neck cancers development

Srpski Arhiv za Celokupno Lekarstvo

Volumn 141, Issue 5-6, 2013, Pages 304-307

  Kostić, Marija ^a   Nikolić, Nadja ^a   Ilić, Branislav ^a   Čarkić, Jelena ^a   Milenković, Sanja ^b   Vukadinović, Miroslav ^a  

^a UNIVERSITY OF BELGRADE   (Serbia)

^b Department of Clinical Pathology Clinical Hospital Centre Zemun ^*  (Serbia)

Author keywords

Head and neck cancers; Polymorphism; Promoter; Survivin

Indexed keywords

APOPTOSIS REGULATORY PROTEIN; BIRC5 PROTEIN, HUMAN; INHIBITOR OF APOPTOSIS PROTEIN;

AGED; AMPLIFIED FRAGMENT LENGTH POLYMORPHISM; BASAL CELL CARCINOMA; CASE CONTROL STUDY; FEMALE; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETICS; HEAD AND NECK TUMOR; HUMAN; MALE; MIDDLE AGED; MOUTH TUMOR; PATHOLOGY; PROMOTER REGION; SKIN TUMOR; SQUAMOUS CELL CARCINOMA;

AGED; AMPLIFIED FRAGMENT LENGTH POLYMORPHISM ANALYSIS; APOPTOSIS REGULATORY PROTEINS; CARCINOMA, BASAL CELL; CARCINOMA, SQUAMOUS CELL; CASE-CONTROL STUDIES; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HEAD AND NECK NEOPLASMS; HUMANS; INHIBITOR OF APOPTOSIS PROTEINS; MALE; MIDDLE AGED; MOUTH NEOPLASMS; POLYMORPHISM, GENETIC; PROMOTER REGIONS, GENETIC; SKIN NEOPLASMS;

EID: 84922687380     PISSN: 03708179     EISSN: None     Source Type: Journal    
DOI: 10.2298/SARH1306304K     Document Type: Article

References (33)

1. Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin. 2005; 55(2):74-108.
2. Silverman Jr S. Demographics and occurrence of oral and pharyngeal cancers. The outcomes, the trends, the challenge. J Am Dent Assoc. 2001; 132 Suppl:7S-11S.
3. Burtness B. Head and neck cancer. Encyclopedia Cancer. 2002; 2:339-46.
4. Williams HK. Molecular pathogenesis of oral squamous cell carcinoma. J Clin Pathol Mol Pathol. 2000; 53(4):165-72.
5. Tilli CM, Van Steensel MA, Krekels GA, Neumann HA, Ramaekers FC. Molecular aetiology and pathogenesis of basal cell carcinoma. Br J Dermatol. 2005; 152(6):1108-24.
6. Holikova Z, Massi D, Lotti T, Hercogova J. Insight into the pathogenesis of sporadic basal cell carcinoma. Int J Dermatol. 2004; 43(12):865-9.
7. Rubin AI, Chen EH, Ratner D. Basal-cell carcinoma. N Engl J Med. 2005; 353(21):2262-9.
8. Christenson LJ, Borrowman TA, Vachon CM, Tollefson MM, Otley CC, Weaver AL, et al. Incidence of basal cell and squamous cell carcinomas in a population younger than 40 years. JAMA. 2005; 294(6):681-90.
9. Wünsch Filho V, Zago MA. Modern cancer epidemiological research: genetic polymorphisms and environment. Rev Saude Publica. 2005; 39(3):490-7.
10. Thompson CB. Apoptosis is the pathogenesis and treatment of disease. Science. 1995; 267(5203):1456-62.
11. Raff M. Cell suicide for beginners. Nature. 1998; 396(6707):119-22.
12. Altieri DC. Survivin, versatile modulation of cell division and apoptosis in cancer. Oncogene. 2003; 22(53):8581-9.
13. Mita AC, Mita MM, Nawrocki ST, Giles FJ. Survivin: key regulator of mitosis and apoptosis and novel target for cancer therapeutics. Clin Cancer Res. 2008; 14(16):5000-5.
14. Marioni G, Bedogni A, Giacomelli L, Ferraro SM, Bertolin A, Facco E, et al. Survivin expression is significantly higher in pN+ oral and oropharyngeal primary squamous cell carcinomas than in pN0 carcinomas. Acta Otolaryngol. 2005; 125(11):1218-23.
15. Li F, Ambrosini G, Chu EY, Plescia J, Tognin S, Marchisio PC, et al. Control of apoptosis and mitotic spindle checkpoint by survivin. Nature. 1998; 396(6711):580-4.
16. Altieri DC, Marchisio PC, Marchisio C. Survivin apoptosis: an interloper between cell death and cell proliferation in cancer. Lab Invest. 1999; 79(11):1327-33.
17. Xu Y, Fang F, Ludewig G, Jones G, Jones D. A mutation found in the promoter region of the human survivin gene is correlated to overexpression of survivin in cancer cells. DNA Cell Biol. 2004; 23(9):527-37.
18. Ambrosini G, Adida C, Alteri DC. A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma. Nat Med. 1997; 3(8):917-21.
19. Velculescu VE, Madden SL, Zhang L, Lash AE, Yu J, Rago C, et al. Analysis of human transcriptomes. Nat Genet. 1999; 23(4):387-8.
20. Kawasaki H, Altieri DC, Lu CD, Toyoda M, Tenjo T, Tanigawa N. Inhibition of apoptosis by survivin predicts shorter survival rates in colorectal cancers. Cancer Res. 1998; 58(22):5071-4.
21. Lu CD, Altieri DC, Tanigawa N. Expression of a novel antiapoptosis gene, survivin, correlated with tumor cell apoptosis and p53 accumulation in gastric carcinomas. Cancer Res. 1998; 58(9):1808-12.
22. Monzo M, Rosell R, Felip E, Astudillo J, Sanchez JJ, Maestre J, et al. A novel anti-apoptosis gene: re-expression of surviving messenger RNA as a prognostic marker in non-small-cell lung cancers. J Clin Oncol. 1999; 17(7):2100-04.
23. Tanaka K, Iwamoto S, Gon G, Nohara T, Iwamoto M, Tanigawa N. Expression of survivin and its relationship to loss of apoptosis in breast carcinomas. Clin Cancer Res. 2000; 6(1):127-34.
24. Gianani R, Jarboe E, Orlicky D, Frost M, Bobak J, Lehner R, et al. Expression of survivin in normal, hyperplastic, and neoplastic colonic mucosa. Hum Pathol. 2001; 32(1):119-25.
25. Srivastava K, Srivastava A, Mittal B. Survivin promoter-31G/C (rs9904341) polymorphism and cancer susceptibility: a metaanalysis. Mol Biol Rep. 2012; 39(2):1509-16.
26. Jang JS, Kim KM, Kang KH, Choi JE, Lee WK, Kim CH, et al. Polymorphisms in the survivin gene and the risk of lung cancer. Lung Cancer. 2008; 60(1):31-9.
27. Cheng ZJ, Hu LH, Huang SJ. Correlation of-31G/C polymorphisms of survivin promoter to tumorigenesis of gastric carcinoma. Ai Zheng. 2008; 27(3):258-63.
28. Gazouli M, Tzanakis N, Rallis G, Theodoropoulos G, Papaconstantinou I, Kostakis A, et al. Survivin-31G/C promoter polymorphism and sporadic colorectal cancer. Int J Colorectal Dis. 2009; 24(2):145-50.
29. Borges BD, Burbano RR, Harada ML. Survivin-31C/G polymorphism and gastric cancer risk in a Brazilian population. Clin Exp Med. 2011; 11(3):189-93.
30. Yang L, Zhu H, Zhou B, Gu H, Yan H, Tang N, et al. The association between the survivin C-31G polymorphism and gastric cancer risk in a Chinese population. Dig Dis Sci. 2009; 54(5):1021-8.
31. Andric M, Nikolic N, Boskovic M, Milicic B, Skodric S, Basta Jovanovic G, et al. Survivin gene promoter polymorphism-31G/C as a risk factor for keratocystic odontogenic tumor development. Eur J Oral Sci. 2012; 120(1):9-13.
32. Wagner M, Schmelz K, Dorken B, Tamm I. Epigenetic and genetic analysis of the survivin promoter in acute myeloid leukemia. Leuk Res. 2008; 32(7):1054-60.
33. Borbély ÁA, Murvai M, Szarka K, Kónya J, Gergely L, Hernádi Z, et al. Survivin promoter polymorphism and cervical carcinogenesis. J Clin Pathol. 2007; 60(3):303-6.